Open-label, Phase I study of NeoVax with Nivolumab in Patients with Ovarian Cancer
NOT ENROLLING
Trial ID:
NCT04024878 Protocol # :
18-318
Phase
I
Disease Sites
Ovary
Principal Investigator
Konstantinopoulos, Panagiotis, A.
Site Investigator
Harden, Maegan, V.
Ott, Patrick
Site Research Nurses
Arvine, Lisa, Beth
Baylies, Rosemarie
Bowler, Becky, L.
Cummings, Kelly
Earley, Catherine, B.
Flynn, Laura, Kelly
Gillen Mckay, Christine, A.
Hamel, Alison
Hindenach, Sarah
Hurley-Whalen, Christin
Hurley-Whalen, Christin
Keis, Rylee
Kelley, Kristina
Menon, Susanne
Morrissey, Stephanie, C.
Rowan, Jennifer, M.
Stewart, Ann, M.
Thistle, Katrina, M.
Yager, Naomi, Isabelle
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-318
18-318